Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › VA › Winchester › NPI 1619928017
Supplier

Winchester Medical Center

Winchester Medical Center was paid $69.83M by Medicaid between Jan 2018 and Dec 2024, across 407 billing codes. Its largest line is 99285, emergency room visit (most serious) — 14% of everything it billed.

33Billing provider infoWINCHESTER MEDICAL CENTER
WINCHESTER, VA 22601
33aNPI1619928017assigned 05/12/2006
28Total paid$69.83M
24GClaims1,435,792
24DCodes billed407
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Durable Medical Equipment & Medical Supplies providers in Virginia

Rank by total paid#2 of 229
Median peer was paid$17K
This provider vs. median4,227×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018162,643$6.99M
2019195,559$8.54M
2020189,480$8.76M
2021215,899$9.62M
2022211,831$10.58M
2023247,845$12.30M
2024incomplete212,535$13.04M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 14% 45,653 39,865 $9.65M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 7.8% 29,340 26,091 $5.42M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.7% 32,896 29,693 $5.37M
96361 Intravenous infusion, hydration; each additional hour 6.7% 19,217 15,172 $4.65M
41899 Unlisted procedure, dentoalveolar structures 5.8% 3,066 2,822 $4.06M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.5% 8,897 8,303 $2.44M
G0378 Hospital observation service, per hour 2.6% 12,322 9,868 $1.78M
70450 Computed tomography, head or brain; without contrast material 2.2% 9,457 8,628 $1.55M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.0% 20,776 6,595 $1.39M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.6% 2,229 2,144 $1.10M
74176 Computed tomography, abdomen and pelvis; without contrast material 1.4% 3,925 3,659 $999K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.3% 6,010 4,306 $894K
395 more codes
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.3% 1,350 $879K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.2% 5,552 $854K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.2% 28,753 $837K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.1% 14,303 $778K
71275 Computed tomographic angiography, chest, with contrast material 1.1% 3,317 $778K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.1% 5,189 $757K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.1% 9,689 $743K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.0% 10,449 $721K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.0% 15,480 $705K
36415 Collection of venous blood by venipuncture 1.0% 93,863 $705K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 2,281 $696K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 1,249 $692K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 1,055 $650K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 9,181 $606K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 842 $599K
49083 <1% 1,232 $585K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 7,891 $569K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 2,803 $553K
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml <1% 3,084 $544K
70551 Magnetic resonance imaging, brain; without contrast material <1% 2,132 $509K
76819 Fetal biophysical profile; without non-stress testing <1% 5,473 $493K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 2,311 $453K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 4,287 $436K
97161 <1% 4,468 $433K
43235 <1% 929 $423K
59025 Fetal non-stress test <1% 2,253 $405K
71046 Radiologic examination, chest; 2 views <1% 23,411 $361K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 6,121 $352K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 89,060 $331K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 3,569 $326K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 3,530 $319K
80053 Comprehensive metabolic panel <1% 50,558 $315K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 963 $303K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 1,118 $277K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 1,391 $255K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 35,997 $241K
80048 Basic metabolic panel (calcium, ionized) <1% 33,269 $224K
76770 <1% 1,936 $223K
93971 <1% 2,432 $215K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 309 $204K
J2704 Injection, propofol, 10 mg <1% 15,767 $201K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 15,555 $200K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 14,070 $195K
78815 Positron emission tomography (PET) for limited area imaging <1% 262 $190K
G0330 Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room <1% 105 $189K
29581 <1% 1,318 $188K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,596 $185K
77067 Screening mammography, bilateral, including computer-aided detection <1% 3,071 $183K
96375 Therapeutic injection; each additional sequential IV push <1% 19,100 $181K
S9480 Intensive outpatient psychiatric services, per diem <1% 775 $181K
96376 <1% 11,849 $179K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 8,396 $176K
93325 <1% 1,135 $171K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 4,518 $170K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 6,247 $152K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 10,202 $148K
76801 <1% 3,359 $147K
80047 <1% 14,734 $141K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,783 $137K
77386 <1% 414 $135K
76830 Ultrasound, transvaginal <1% 1,279 $132K
J3490 Unclassified drugs <1% 23,913 $128K
76641 <1% 1,136 $126K
71250 <1% 1,887 $126K
84443 Thyroid stimulating hormone (TSH) <1% 13,115 $126K
93017 <1% 1,529 $122K
P9047 Infusion, albumin (human), 25%, 50 ml <1% 291 $119K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,168 $118K
97165 <1% 1,738 $115K
76813 <1% 1,205 $110K
77336 <1% 1,386 $109K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 94 $109K
77412 <1% 278 $99K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,662 $99K
93970 <1% 839 $95K
83880 <1% 6,786 $93K
82948 <1% 17,609 $90K
84484 <1% 23,147 $89K
80061 Lipid panel <1% 8,734 $89K
86901 <1% 4,831 $89K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 4,295 $89K
C1769 Guide wire <1% 3,376 $84K
81001 <1% 28,402 $76K
72125 Computed tomography, cervical spine; without contrast material <1% 2,664 $74K
97602 <1% 657 $72K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 14,288 $71K
97116 <1% 2,260 $69K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 6,408 $67K
93925 <1% 756 $67K
76820 <1% 1,389 $66K
83036 Hemoglobin; glycosylated (A1C) <1% 8,931 $63K
73610 <1% 2,822 $62K
97162 <1% 639 $60K
85610 <1% 15,000 $55K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 1,302 $54K
87086 Culture, bacterial; quantitative colony count, urine <1% 13,056 $54K
73502 <1% 2,248 $54K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 1,142 $53K
74018 <1% 2,381 $53K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 2,541 $53K
73564 <1% 2,867 $52K
73630 <1% 2,214 $51K
72110 <1% 1,106 $51K
87420 <1% 2,613 $51K
71045 Radiologic examination, chest; single view <1% 10,817 $49K
73030 <1% 2,482 $48K
76642 <1% 480 $48K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 4,155 $47K
12001 <1% 194 $45K
85379 <1% 5,685 $44K
77066 Tomosynthesis, mammo <1% 750 $44K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 748 $44K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 106 $44K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 5,451 $43K
72100 <1% 2,496 $43K
97535 Self-care/home management training, each 15 minutes <1% 1,254 $43K
87040 <1% 3,621 $42K
76536 <1% 398 $42K
83690 <1% 11,023 $41K
52356 <1% 13 $41K
80076 <1% 6,304 $40K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 8,117 $40K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 8,042 $38K
87070 <1% 3,569 $36K
76825 <1% 451 $36K
73130 <1% 1,626 $36K
72141 <1% 221 $34K
84703 <1% 11,752 $34K
76818 <1% 298 $32K
74019 <1% 987 $32K
70496 <1% 151 $30K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,204 $30K
84702 <1% 5,390 $30K
J7050 Infusion, normal saline solution, 250 cc <1% 8,013 $30K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,831 $30K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 11,269 $29K
84112 <1% 1,010 $29K
82947 <1% 5,547 $28K
71271 <1% 261 $28K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 12,057 $28K
83735 <1% 11,147 $27K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 1,372 $27K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,289 $27K
97597 <1% 821 $26K
83970 <1% 1,095 $26K
90853 Group psychotherapy (other than of a multiple-family group) <1% 172 $26K
92609 <1% 568 $25K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,201 $25K
73110 <1% 1,125 $25K
97113 <1% 405 $24K
87634 <1% 1,062 $24K
J2270 Injection, morphine sulfate, up to 10 mg <1% 5,260 $24K
J0690 Injection, cefazolin sodium, 500 mg <1% 5,732 $23K
88341 <1% 627 $23K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 15 $23K
85027 <1% 3,684 $22K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 895 $22K
J1644 Injection, heparin sodium, per 1000 units <1% 5,534 $22K
77334 <1% 90 $22K
82607 <1% 3,079 $21K
J1815 Injection, insulin, per 5 units <1% 1,466 $21K
J1650 Injection, enoxaparin sodium, 10 mg <1% 5,586 $21K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 2,677 $21K
86140 <1% 6,036 $21K
70491 <1% 109 $20K
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 1,521 $20K
81025 <1% 3,260 $20K
72040 <1% 820 $20K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 320 $20K
93880 <1% 240 $19K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 5,931 $19K
86618 <1% 1,452 $19K
76827 <1% 465 $19K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 871 $19K
88342 <1% 1,343 $19K
97163 <1% 201 $18K
77065 Tomosynthesis, mammo <1% 371 $18K
85652 <1% 4,734 $17K
87077 <1% 2,991 $17K
81003 <1% 5,479 $17K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 1,129 $17K
84439 <1% 3,330 $17K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 243 $16K
73590 <1% 901 $16K
85730 <1% 5,268 $16K
82746 <1% 2,512 $15K
76870 <1% 159 $15K
12011 <1% 52 $14K
93458 <1% 12 $14K
J1170 Injection, hydromorphone, up to 4 mg <1% 6,591 $14K
82728 <1% 2,262 $14K
82565 <1% 1,913 $14K
86850 <1% 4,181 $13K
94060 <1% 324 $13K
88304 <1% 971 $13K
82803 <1% 2,050 $13K
A4217 Sterile water/saline, 500 ml <1% 1,007 $13K
84466 <1% 2,254 $13K
94660 <1% 51 $12K
87081 <1% 5,111 $12K
86900 <1% 4,831 $11K
83605 <1% 3,781 $11K
80074 <1% 352 $11K
84550 <1% 2,251 $11K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 58 $11K
93922 <1% 263 $11K
93660 <1% 71 $10K
94726 <1% 176 $10K
86803 <1% 1,172 $10K
80143 <1% 2,477 $10K
94729 <1% 203 $10K
87186 <1% 4,806 $10K
87301 <1% 2,505 $10K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 2,001 $10K
70498 <1% 181 $10K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 1,849 $9K
97166 <1% 109 $9K
87205 <1% 3,100 $9K
84100 <1% 4,621 $8K
10061 <1% 58 $8K
83540 <1% 2,375 $8K
87046 <1% 661 $7K
82570 <1% 2,745 $7K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,419 $7K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 27 $7K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 24 $7K
J3535 Drug administered through a metered dose inhaler <1% 897 $7K
93351 <1% 16 $7K
10005 <1% 12 $7K
76821 <1% 124 $6K
82550 <1% 2,522 $6K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 2,247 $6K
70486 <1% 172 $6K
G0379 Direct admission of patient for hospital observation care <1% 264 $6K
87045 <1% 530 $6K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 971 $6K
84145 <1% 673 $6K
97012 <1% 190 $6K
12002 <1% 26 $6K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,100 $6K
95806 <1% 39 $6K
88307 <1% 124 $5K
73090 <1% 385 $5K
97167 <1% 77 $5K
73080 <1% 318 $5K
73140 <1% 261 $5K
80179 <1% 2,278 $5K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 2,285 $5K
J2785 Injection, regadenoson, 0.1 mg <1% 228 $5K
72131 <1% 80 $4K
92610 <1% 42 $4K
J8540 Dexamethasone, oral, 0.25 mg <1% 666 $4K
87340 <1% 867 $4K
43249 <1% 12 $4K
J2550 Injection, promethazine hcl, up to 50 mg <1% 470 $4K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring <1% 15 $4K
J2060 Injection, lorazepam, 2 mg <1% 1,894 $4K
76937 <1% 244 $4K
92523 <1% 30 $4K
85018 <1% 1,582 $4K
80069 <1% 929 $4K
87210 <1% 804 $4K
74183 <1% 12 $4K
84156 <1% 2,224 $4K
85014 <1% 2,391 $4K
86592 <1% 577 $3K
93976 <1% 41 $3K
73552 <1% 122 $3K
95886 <1% 61 $3K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,715 $3K
87088 <1% 1,270 $3K
93000 <1% 703 $3K
36600 <1% 363 $3K
85007 <1% 887 $2K
36430 <1% 31 $2K
29125 <1% 71 $2K
77300 <1% 44 $2K
87400 <1% 282 $2K
A9585 Injection, gadobutrol, 0.1 ml <1% 194 $2K
86706 <1% 369 $2K
36416 <1% 465 $2K
84132 <1% 665 $2K
82075 <1% 513 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 304 $2K
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 818 $2K
86038 <1% 321 $2K
88360 <1% 44 $2K
72050 <1% 36 $2K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 833 $2K
J7510 Prednisolone oral, per 5 mg <1% 485 $2K
77080 <1% 25 $2K
90715 <1% 81 $2K
87493 <1% 111 $2K
75625 <1% 12 $2K
73560 <1% 43 $1K
43450 <1% 59 $1K
90714 <1% 67 $1K
86920 <1% 178 $1K
82043 <1% 554 $1K
J3370 Injection, vancomycin hcl, 500 mg <1% 1,441 $1K
82140 <1% 226 $1K
83655 <1% 69 $1K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 1,342 $1K
J3475 Injection, magnesium sulfate, per 500 mg <1% 962 $968.13
86430 <1% 193 $934.74
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 886 $867.48
80081 <1% 13 $789.97
93226 <1% 15 $734.41
J2560 Injection, phenobarbital sodium, up to 120 mg <1% 79 $688.50
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 37 $667.83
84436 <1% 156 $665.84
82248 <1% 262 $663.57
87522 Neg quan hep c or qual rna <1% 31 $635.77
71101 <1% 74 $556.28
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 14 $555.16
74022 <1% 46 $545.19
J0780 Injection, prochlorperazine, up to 10 mg <1% 2,428 $529.59
82010 <1% 458 $486.88
94664 <1% 91 $469.24
83615 <1% 224 $464.00
C1726 Catheter, balloon dilatation, non-vascular <1% 182 $407.38
J1630 Injection, haloperidol, up to 5 mg <1% 710 $398.35
82330 <1% 129 $364.51
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 369 $359.97
99152 <1% 485 $359.88
93225 <1% 15 $356.81
80164 <1% 62 $343.61
72072 <1% 12 $334.23
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 203 $324.33
82150 <1% 163 $316.67
J1940 Injection, furosemide, up to 20 mg <1% 850 $308.40
70360 <1% 16 $273.21
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) <1% 458 $271.39
72070 <1% 14 $269.62
73620 <1% 12 $237.26
82784 <1% 56 $226.88
82950 <1% 44 $224.81
01999 <1% 99 $221.10
C1776 Joint device (implantable) <1% 12 $209.56
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 25 $207.37
87425 <1% 13 $181.78
84403 <1% 13 $176.71
93320 <1% 13 $164.14
86308 <1% 162 $156.53
87428 <1% 14 $128.78
87147 <1% 167 $120.10
88173 <1% 14 $120.06
86160 <1% 29 $114.98
82247 <1% 16 $112.31
J1756 Injection, iron sucrose, 1 mg <1% 98 $98.66
89051 <1% 146 $96.90
86664 <1% 12 $95.54
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 481 $93.62
86364 <1% 14 $92.46
J3480 Injection, potassium chloride, per 2 meq <1% 206 $84.46
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 220 $84.19
73060 <1% 12 $77.40
99153 Mod sedat endo service >5yrs <1% 146 $73.24
85347 <1% 42 $70.08
84295 <1% 44 $68.99
J1643 Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units <1% 141 $67.99
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 262 $65.10
86787 <1% 14 $62.03
87260 <1% 21 $51.06
J1790 Injection, droperidol, up to 5 mg <1% 476 $49.52
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 466 $32.99
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 105 $30.17
J7999 Compounded drug, not otherwise classified <1% 846 $28.01
82365 <1% 27 $25.51
86665 <1% 24 $13.10
87015 <1% 16 $12.32
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 842 $10.39
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 171 $5.87
J0360 Injection, hydralazine hcl, up to 20 mg <1% 33 $4.48
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 483 $4.03
J1171 Injection, hydromorphone, 0.1 mg <1% 171 $3.06
C9113 Injection, pantoprazole sodium, per vial <1% 148 $2.87
J1596 Injection, glycopyrrolate, 0.1 mg <1% 297 $1.76
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 96 $0.26
S0028 Injection, famotidine, 20 mg <1% 278 $0.04
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 278 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 32 $0.00
J3371 Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg 0% 68 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 1,533 $0.00
J0735 Injection, clonidine hydrochloride, 1 mg 0% 12 $0.00
C1758 Catheter, ureteral 0% 40 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 0% 118 $0.00
29515 0% 12 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 13 $0.00
C2617 Stent, non-coronary, temporary, without delivery system 0% 68 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 52 $0.00
81000 0% 20 $0.00
V2632 Posterior chamber intraocular lens 0% 37 $0.00
77001 0% 16 $0.00
A9152 Single vitamin/mineral/trace element, oral, per dose, not otherwise specified 0% 42 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAMOS, ROBERT (VP & CFO)